Jane Mitchell

Last updated

Jane Mitchell is a professor of pharmacology in clinical care medicine at Imperial College London. [1] Her research focusses on the regulation of cardiovascular health and disease, with a particular interest in endothelial cells, prostacyclin (a platelet activator and vasodilator), and nitric oxide. [2]

She finished her PhD with Nobel Laureate John Vane and worked as a postdoctoral fellow with another Nobel Laureate: Ferid Murad. She became a professor when she was 38. [2] Mitchell won the Novartis Prize for Pharmacology in 1999 for her work on cyclooxygeanse biology. [1] In 2012, she won the AstraZeneca Prize for Women in Pharmacology. [3]

Mitchell grew up in a coal mining town. People around her frequently died young from cardiovascular and respiratory diseases, which inspired her to pursue a career in clinical research, with a focus on hearts and lungs. [2] She studied biological sciences at Lancaster University. [2]

Related Research Articles

<span class="mw-page-title-main">Karolinska Institute</span> Medical university located in Stockholm, Sweden

The Karolinska Institute is a research-led medical university in Solna within the Stockholm urban area of Sweden and one of the foremost medical research institutes globally. The Nobel Assembly at the Karolinska Institute awards the Nobel Prize in Physiology or Medicine. The assembly consists of fifty professors from various medical disciplines at the university. The current vice-chancellor of Karolinska Institute is Annika Östman Wernerson, who took office in March 2023.

<span class="mw-page-title-main">Gerty Cori</span> Czech-American biochemist (1896–1957)

Gerty Theresa Cori was an Austrian-American biochemist who in 1947 was the third woman to win a Nobel Prize in science, and the first woman to be awarded the Nobel Prize in Physiology or Medicine, for her role in the "discovery of the course of the catalytic conversion of glycogen".

<span class="mw-page-title-main">Ferid Murad</span> American physician and pharmacologist (1936–2023)

Ferid Murad was an American physician and pharmacologist, and a co-winner of the 1998 Nobel Prize in Physiology or Medicine.

<span class="mw-page-title-main">James Black (pharmacologist)</span> Scottish doctor and pharmacologist (1924–2010)

Sir James Whyte Black was a Scottish physician and pharmacologist. Together with Gertrude B. Elion and George H. Hitchings, he shared the Nobel Prize for Medicine in 1988 for pioneering strategies for rational drug-design, which, in his case, lead to the development of propranolol and cimetidine. Black established a Veterinary Physiology department at the University of Glasgow, where he became interested in the effects of adrenaline on the human heart. He went to work for ICI Pharmaceuticals in 1958 and, while there, developed propranolol, a beta blocker used for the treatment of heart disease. Black was also responsible for the development of cimetidine, an H2 receptor antagonist, a drug used to treat stomach ulcers.

<span class="mw-page-title-main">Robert F. Furchgott</span> American biochemist (1916–2009)

Robert Francis Furchgott was a Nobel Prize-winning American biochemist who contributed to the discovery of nitric oxide as a transient cellular signal in mammalian systems.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

<span class="mw-page-title-main">Rosalyn Sussman Yalow</span> American medical physicist

Rosalyn Sussman Yalow was an American medical physicist, and a co-winner of the 1977 Nobel Prize in Physiology or Medicine for development of the radioimmunoassay technique. She was the second woman, and the first American-born woman, to be awarded the Nobel Prize in Physiology or Medicine.

<span class="mw-page-title-main">Johns Hopkins School of Medicine</span> Medical school of Johns Hopkins University

The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.

Imperial College School of Medicine (ICSM) is the undergraduate medical school of Imperial College London in England and one of the United Hospitals. It is part of the college's Faculty of Medicine and was formed by the merger of several historic medical schools. It's core campuses are located at South Kensington, St Mary's, Charing Cross, Hammersmith and Chelsea and Westminster. The school ranked 3rd in the world for medicine in the 2022 Times Higher Education World University Rankings.

<span class="mw-page-title-main">University of Virginia School of Medicine</span> Public medical school in Charlottesville, Virginia, US

The University of Virginia School of Medicine is the graduate medical school of the University of Virginia. The school's facilities are on the University of Virginia grounds adjacent to Academical Village in Charlottesville, Virginia. Founded in 1819 by Thomas Jefferson, UVA SoM is the tenth oldest medical school in the United States. The School of Medicine confers Doctor of Medicine (M.D.) and Doctor of Philosophy (PhD) degrees, and is closely associated with both the University of Virginia Health System and Inova Health System.

<span class="mw-page-title-main">Robert Lefkowitz</span> American physician and biochemist

Robert Joseph Lefkowitz is an American physician and biochemist. He is best known for his discoveries that reveal the inner workings of an important family G protein-coupled receptors, for which he was awarded the 2012 Nobel Prize for Chemistry with Brian Kobilka. He is currently an Investigator with the Howard Hughes Medical Institute as well as a James B. Duke Professor of Medicine and Professor of Biochemistry and Chemistry at Duke University.

Stefanie Dimmeler is a German biologist specializing in the pathophysiological processes underlying cardiovascular diseases. Her awards and honours include the Gottfried Wilhelm Leibniz Prize of the German Research Foundation for her work on the programmed cell death of endothelial cells. Since 2008 she has led the Institute for Cardiovascular Regeneration at the University of Frankfurt. Her current work is focusing to develop cellular and pharmacological strategies to improve cardiovascular repair and regeneration. Her work aims to establish non-coding RNAs as novel therapeutic targets.

<span class="mw-page-title-main">Tu Youyou</span> Chinese pharmaceutical chemist (born 1930)

Tu Youyou is a Chinese malariologist and pharmaceutical chemist. She discovered artemisinin and dihydroartemisinin, used to treat malaria, a breakthrough in twentieth-century tropical medicine, saving millions of lives in South China, Southeast Asia, Africa, and South America.

<span class="mw-page-title-main">Ada Yonath</span> Israeli chemist (born 1939)

Ada E. Yonath is an Israeli crystallographer and Nobel laureate in Chemistry, best known for her pioneering work on the structure of ribosomes. She is the current director of the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly of the Weizmann Institute of Science.

The Massry Prize was established in 1996, and was administered by the Meira and Shaul G. Massry Foundation until 2019. The Prize, of $40,000 and the Massry Lectureship, is bestowed upon scientists who have made substantial recent contributions in the biomedical sciences. Shaul G. Massry, M.D., who established the Massry Foundation, is Professor Emeritus of Medicine and Physiology and Biophysics at the Keck School of Medicine, University of Southern California. He served as Chief of its Division of Nephrology from 1974 to 2000. In 2009 the KECK School of Medicine was asked to administer the Prize, and has done so since that time. Ten winners of the Massry Prize have gone on to be awarded a Nobel Prize.

Garret Adare FitzGerald is an Irish physician. He is professor of in translational medicine and Therapeutics and chair of the department of pharmacology at the Perelman School of Medicine of the University of Pennsylvania. He researches aspects of cardiology, pharmacology, translational medicine, and chronobiology.

<span class="mw-page-title-main">Katalin Karikó</span> Hungarian-American biochemist (born 1955)

Katalin "Kati" Karikó is a Hungarian-American biochemist who specializes in ribonucleic acid (RNA)-mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy. Karikó laid the scientific groundwork for mRNA vaccines, overcoming major obstacles and skepticism in the scientific community. Karikó received the Nobel Prize in Physiology or Medicine in 2023 for her work, along with American immunologist Drew Weissman.

Emma Harriet Baker is a British professor of clinical pharmacology and consultant physician in internal medicine at St George's Hospital, London. She has a specialist interest in people who have multiple medical conditions at the same time and take several medications, with a particular focus on lung disease. She is director of the UK's first BSc in clinical pharmacology, clinical vice president of the British Pharmacological Society and training programme director at Health Education England.

<span class="mw-page-title-main">Robert M. Graham (cardiologist)</span> Australian medical researcher

Robert Michael Graham AO, FAA, FAHMS is an Australian-born clinician-scientist. He is the Des Renford Professor of Medicine at University of New South Wales and the Head of the Molecular Cardiology and Biophysics Division at Victor Chang Cardiac Research Institute.

<span class="mw-page-title-main">Amrita Ahluwalia</span> British pharmacologist and Professor

Amrita Ahluwalia is a British pharmacologist and professor of vascular pharmacology at Queen Mary University of London. Her research considers the development of therapeutics for cardiovascular inflammation. She was awarded the WISE Research Award in 2015.

References

  1. 1 2 "Professor Jane Mitchell". www.imperial.ac.uk. Retrieved 2024-03-09.
  2. 1 2 3 4 "Meet the First Authors". Circulation Research. 125 (9): 784–786. 2019-10-11. doi:10.1161/RES.0000000000000304. ISSN   0009-7330.
  3. "Annual Review 2012" (PDF). British Pharmalogical Society. 2012. Retrieved 8 March 2024.